US investigating liver injury reports with orlistat
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is investigating reports of liver injury with the weight loss product orlistat, marketed as Roche’s prescription drug Xenical and GlaxoSmithKline’s over-the-counter product alli1.